Brief: ABVC BioPharma Introduces Dietary Supplement Based On Maitake Mushroom Enters Into $3 Million Distribution Agreement

ABVC Biopharma

09/12/2021 13:47

Dec 9 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA INTRODUCES DIETARY SUPPLEMENT BASED ON
MAITAKE
MUSHROOM, ENTERS INTO $3.0 MILLION DISTRIBUTION AGREEMENT
    * ABVC BIOPHARMA INC- BIOKEY, A WHOLLY-OWNED SUBSIDIARY OF
CO WILL
PRODUCE DIETARY SUPPLEMENTS DERIVED FROM MAITAKE MUSHROOM IN
BOTH TABLET, LIQUID FORM
    * ABVC BIOPHARMA INC- BIOKEY HAS ENTERED INTO A THREE-YEAR
DISTRIBUTION AGREEMENT WITH DEFINE BIOTECH CO. LTD
    * ABVC BIOPHARMA INC- AGREEMENT GRANTS DEFINE BIOTECH
EXCLUSIVE
RIGHT TO DISTRIBUTE  NEW DIETARY SUPPLEMENT IN CHINA AND TAIWAN
    * ABVC BIOPHARMA INC- AGREEMENT WITH DEFINE BIOTECH IN
EXCHANGE
FOR COMMITMENT TO PURCHASE $3.0 MILLION WORTH OF NEW PRODUCT
OVER THREE-YEAR PERIOD
    * ABVC BIOPHARMA INC- BASED ON AGREEMENT WITH DEFINE
BIOTECH,
EXPECT SUBSIDIARY IN CALIFORNIA TO ACHIEVE FINANCIAL
PROFITABILITY BY 2022 END

Source text for Eikon:  ID:nGNX597Xvs 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))